- Home
- AMRN vs CV Comparison
AMRN vs CV Comparison
Compare AMRN & CV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRN
- CV
- Stock Information
- Founded
- AMRN 1989
- CV 2005
- Country
- AMRN Ireland
- CV United States
- Employees
- AMRN N/A
- CV N/A
- Industry
- AMRN Biotechnology: Pharmaceutical Preparations
- CV
- Sector
- AMRN Health Care
- CV
- Exchange
- AMRN Nasdaq
- CV NYSE
- Market Cap
- AMRN 216.0M
- CV 194.2M
- IPO Year
- AMRN 1993
- CV 2025
- Fundamental
- Price
- AMRN $14.52
- CV $3.87
- Analyst Decision
- AMRN Strong Sell
- CV Buy
- Analyst Count
- AMRN 1
- CV 1
- Target Price
- AMRN $12.00
- CV $5.00
- AVG Volume (30 Days)
- AMRN 88.3K
- CV 460.3K
- Earning Date
- AMRN 07-30-2025
- CV 01-01-0001
- Dividend Yield
- AMRN N/A
- CV N/A
- EPS Growth
- AMRN N/A
- CV N/A
- EPS
- AMRN N/A
- CV N/A
- Revenue
- AMRN $219,361,000.00
- CV $12,044,000.00
- Revenue This Year
- AMRN N/A
- CV N/A
- Revenue Next Year
- AMRN N/A
- CV N/A
- P/E Ratio
- AMRN N/A
- CV N/A
- Revenue Growth
- AMRN N/A
- CV 20.54
- 52 Week Low
- AMRN $7.08
- CV $3.49
- 52 Week High
- AMRN $17.49
- CV $5.72
- Technical
- Relative Strength Index (RSI)
- AMRN 42.13
- CV N/A
- Support Level
- AMRN $14.45
- CV N/A
- Resistance Level
- AMRN $15.61
- CV N/A
- Average True Range (ATR)
- AMRN 0.60
- CV 0.00
- MACD
- AMRN -0.30
- CV 0.00
- Stochastic Oscillator
- AMRN 5.88
- CV 0.00
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About CV CAPSOVISION INC
CapsoVision Inc is a commercial-stage medical technology enterprise, innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. Internal GI imaging facilitates earlier detection of colorectal cancer and other diseases, enabling more timely and effective treatment regimens for patients. The Company's core technology platform is an orally ingestable capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. The Company's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D directed at the large intestines.